These findings offered evidence for a new mechanism of RIPK1 inhibitor on ALI treatment, suggesting a role in direct inhibition of neutrophil activation and endothelial cell damage through a cell-death-independent manner. Here, RIPK1 is linked to acute respiratory distress syndrome.